This negative association between regional CBF and measures of tau pathophysiology is consistent with prior research that describes cerebrovascular dysfunction and CBF reduction as a well-established characteristic of Alzheimer’s disease in clinical populations.1,28-30. The gene discussed is MAPT; the disease is Alzheimer disease.